GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $400,000 | -10.1% | 10,855 | -8.1% | 0.00% | -40.0% |
| Q3 2020 | $445,000 | +2.8% | 11,818 | +11.2% | 0.01% | 0.0% |
| Q2 2020 | $433,000 | -8.8% | 10,624 | -15.3% | 0.01% | -28.6% |
| Q1 2020 | $475,000 | -23.9% | 12,536 | -5.7% | 0.01% | 0.0% |
| Q4 2019 | $624,000 | -3.1% | 13,289 | -11.9% | 0.01% | 0.0% |
| Q3 2019 | $644,000 | -8.5% | 15,089 | -14.2% | 0.01% | 0.0% |
| Q2 2019 | $704,000 | -4.0% | 17,589 | +0.2% | 0.01% | 0.0% |
| Q1 2019 | $733,000 | -10.9% | 17,546 | -18.6% | 0.01% | -22.2% |
| Q4 2018 | $823,000 | -15.9% | 21,546 | -11.6% | 0.01% | +12.5% |
| Q3 2018 | $979,000 | -57.4% | 24,361 | -57.3% | 0.01% | -57.9% |
| Q2 2018 | $2,298,000 | +15.1% | 56,996 | +11.5% | 0.02% | +18.8% |
| Q1 2018 | $1,996,000 | -19.3% | 51,096 | -26.7% | 0.02% | -20.0% |
| Q4 2017 | $2,473,000 | -18.5% | 69,701 | -6.8% | 0.02% | -16.7% |
| Q3 2017 | $3,036,000 | -6.4% | 74,781 | -0.7% | 0.02% | -11.1% |
| Q2 2017 | $3,245,000 | -9.0% | 75,271 | -11.0% | 0.03% | -10.0% |
| Q1 2017 | $3,567,000 | +2.1% | 84,617 | -6.8% | 0.03% | +15.4% |
| Q4 2016 | $3,495,000 | -9.1% | 90,756 | +1.8% | 0.03% | -10.3% |
| Q3 2016 | $3,843,000 | +6.9% | 89,111 | +7.4% | 0.03% | +7.4% |
| Q2 2016 | $3,596,000 | -5.3% | 82,966 | -11.4% | 0.03% | -3.6% |
| Q1 2016 | $3,799,000 | -7.5% | 93,676 | -7.9% | 0.03% | -3.4% |
| Q4 2015 | $4,105,000 | +148.6% | 101,733 | +137.0% | 0.03% | +141.7% |
| Q3 2015 | $1,651,000 | -26.9% | 42,925 | -20.9% | 0.01% | -20.0% |
| Q2 2015 | $2,260,000 | -6.1% | 54,245 | +4.0% | 0.02% | +25.0% |
| Q1 2015 | $2,408,000 | -26.8% | 52,181 | -32.2% | 0.01% | -14.3% |
| Q4 2014 | $3,290,000 | +18.0% | 76,985 | +26.9% | 0.01% | +27.3% |
| Q3 2014 | $2,788,000 | -12.1% | 60,645 | +2.3% | 0.01% | -15.4% |
| Q2 2014 | $3,170,000 | +40.0% | 59,275 | +39.8% | 0.01% | +44.4% |
| Q1 2014 | $2,265,000 | -41.5% | 42,400 | -41.5% | 0.01% | -43.8% |
| Q4 2013 | $3,872,000 | +128.0% | 72,520 | +114.3% | 0.02% | +100.0% |
| Q3 2013 | $1,698,000 | -49.8% | 33,835 | -50.0% | 0.01% | 0.0% |
| Q2 2013 | $3,382,000 | – | 67,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |